Long-term safety and efficacy of N8-GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2.

Giangrande, Paul; Abdul Karim, Faraizah; Nemes, Laszlo; You, Chur Woo; Landorph, Andrea; Geybels, Milan S; Curry, Nicola

Giangrande, Paul; Abdul Karim, Faraizah; Nemes, Laszlo; You, Chur Woo; Landorph, Andrea; Geybels, Milan S; Curry, Nicola.

Afiliación

Giangrande P; Department of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK.
Abdul Karim F; National Blood Centre, Kuala Lumpur, Malaysia.
Nemes L; National Hemophilia Center and Hemostasis Department, Medical Center of the Hungarian Defence Forces, Budapest, Hungary.
You CW; Pediatric Department, Eulji University Hospital, Daejeon, Korea.
Landorph A; Novo Nordisk A/S, Søborg, Denmark.
Geybels MS; Novo Nordisk A/S, Søborg, Denmark.
Curry N; Oxford Haemophilia and Thrombosis Centre and Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, UK.

J Thromb Haemost ; 18 Suppl 1: 5-14, 2020 09.

Article en En | MEDLINE | ID: mdl-32544297

Asunto(s)

Factor VIII/uso terapéutico; Hemofilia A/tratamiento farmacológico; Hemorragia/inducido químicamente; Adolescente; Adulto; Factor VIII/efectos adversos; Factor VIIa; Semivida; Hemofilia A/diagnóstico; Hemorragia/epidemiología; Hemostasis; Humanos; Medición de Resultados Informados por el Paciente; Resultado del Tratamiento

Palabras clave

clinical trial; factor VIII; hemophilia A; turoctocog alfa pegol

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor VIII / Hemofilia A / Hemorragia Tipo de estudio: Diagnostic_studies Límite: Adolescent / Adult / Humans Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google